|
|
||||||||
1 Department of Clinical Sciences, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK
and2 Department of Pathology, Washington University School of Medicine, Campus Box 8118, 660 S. Euclid Avenue, St Louis, MO 63110, USA
The EpsteinBarr virus (EBV) BZLF1 gene product, Zta is able to trigger the viral lytic cycle in latently infected B lymphocytes. Investigations into regulation of the promoter, Zp for the BZLF1 gene in B cells have identified 12-O-tetradecanoylphorbol 13-acetate, anti-immunoglobulin and Zta responsive elements as well as a negative regulatory element within Zp. EBV infects and replicates within squamous epithelial cells and there is evidence to indicate that EBV gene expression is linked to the differentiation status of epithelial cells. We have investigated regulation of Zp in undifferentiated and differentiated cells of the human squamous epithelial cell line SCC12F. Zp was found to be active in SCC12F cells and activity was increased approximately 7-fold upon induction of epithelial terminal differentiation. Sequences responsive to epithelial cell differentiation were contained within the region of Zp from -86 to +12 bp, a region previously shown to contain an AP-1-like binding site, designated the ZII domain. In addition, enhancing sequences were detected in the region -221 to -86 bp. These studies will lead to a greater understanding of differentiation-linked EBV gene expression in human squamous epithelial cells.
* Author for correspondence. Present address: Department of Histopathology, King's College School of Medicine and Dentistry, Bessemer Road, London SE5 9PJ, UK. Fax +44 171 46 3670.
Received 3 August 1994;
accepted 21 November 1994.
This article has been cited by other articles:
![]() |
R. J. Jones, S. Dickerson, P. M. Bhende, H.-J. Delecluse, and S. C. Kenney Epstein-Barr Virus Lytic Infection Induces Retinoic Acid-responsive Genes through Induction of a Retinol-metabolizing Enzyme, DHRS9 J. Biol. Chem., March 16, 2007; 282(11): 8317 - 8324. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lavens, E. A. Faust, F. Lu, M. Jacob, M. Leta, P. M. Lieberman, and E. Pure Identification of Protein Tyrosine Kinases Required for B-Cell- Receptor-Mediated Activation of an Epstein-Barr Virus Immediate-Early Gene Promoter J. Virol., August 15, 2004; 78(16): 8543 - 8551. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. K. Hong, H.-J. Delecluse, H. Gruffat, T. E. Morrison, W.-H. Feng, A. Sergeant, and S. C. Kenney The BRRF1 Early Gene of Epstein-Barr Virus Encodes a Transcription Factor That Enhances Induction of Lytic Infection by BRLF1 J. Virol., May 15, 2004; 78(10): 4983 - 4992. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Flemington Herpesvirus Lytic Replication and the Cell Cycle: Arresting New Developments J. Virol., May 15, 2001; 75(10): 4475 - 4481. [Full Text] |
||||
![]() |
A. Rodriguez, E. J. Jung, and E. K. Flemington Cell Cycle Analysis of Epstein-Barr Virus-Infected Cells following Treatment with Lytic Cycle-Inducing Agents J. Virol., May 15, 2001; 75(10): 4482 - 4489. [Abstract] [Full Text] |
||||
![]() |
P MacCallum, L Karimi, and L. Nicholson Definition of the transcription factors which bind the differentiation responsive element of the Epstein--Barr virus BZLF1 Z promoter in human epithelial cells J. Gen. Virol., June 1, 1999; 80(6): 1501 - 1512. [Abstract] |
||||
![]() |
A.I. Meisler, V. Schuster, T. Pukrop, and N. Raab-Traub Epstein-Barr Virus and Nasopharyngeal Cancer N. Engl. J. Med., January 11, 1996; 334(2): 122 - 123. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |